1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Lyophilization Services for Biopharmaceuticals Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Lyophilization Services for Biopharmaceuticals Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Demand for Lyophilized Products
- 5.1.2 Rapid Growth in Contract Manufacturing and Lyophilization Services Across the World
5.2 Market Opportunities
- 5.2.1 Launch of Advanced Lyophilization Technology
5.3 Future Trends
- 5.3.1 Growth in the Number of siRNA and Antibody Based Formulations
5.4 Impact of Drivers and Restraints
6. Europe Lyophilization Services for Biopharmaceuticals Market Regional Analysis
6.1 Europe Lyophilization Services for Biopharmaceuticals Market Overview
6.2 Europe Lyophilization Services for Biopharmaceuticals Market Revenue 2021-2028 (US$ Million)
6.3 Europe Lyophilization Services for Biopharmaceuticals Market Forecast Analysis
7. Europe Lyophilization Services for Biopharmaceuticals Market Analysis – by Service Type
7.1 Lyophilization Cycle Development
- 7.1.1 Overview
- 7.1.2 Lyophilization Cycle Development: Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Clinical Manufacturing
- 7.2.1 Overview
- 7.2.2 Clinical Manufacturing: Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Commercial Manufacturing
- 7.3.1 Overview
- 7.3.2 Commercial Manufacturing: Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Freeze Drying Analytical Services
- 7.4.1 Overview
- 7.4.2 Freeze Drying Analytical Services: Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Lyophilization Services for Biopharmaceuticals Market Analysis – by End User
8.1 Pharmaceutical & Biotechnology Companies
- 8.1.1 Overview
- 8.1.2 Pharmaceutical & Biotechnology Companies: Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Research Institutes
- 8.2.1 Overview
- 8.2.2 Research Institutes: Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Lyophilization Services for Biopharmaceuticals Market – Europe Analysis
9.1 Europe
- 9.1.1 Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 9.1.1.1 Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 UK:
Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 UK: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by Service Type
- 9.1.1.1.2 UK: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by End User
- 9.1.1.2 Germany:
Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Germany: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by Service Type
- 9.1.1.2.2 Germany: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by End User
- 9.1.1.3 France:
Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 France: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by Service Type
- 9.1.1.3.2 France: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by End User
- 9.1.1.4 Russia:
Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.4.1 Russia: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by Service Type
- 9.1.1.4.2 Russia: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by End User
- 9.1.1.5 Italy:
Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.5.1 Italy: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by Service Type
- 9.1.1.5.2 Italy: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by End User
- 9.1.1.6 Rest of Europe:
Europe Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.6.1 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by Service Type
- 9.1.1.6.2 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Europe Lyophilization Services for Biopharmaceuticals Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Berkshire Sterile Manufacturing
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Biofortuna
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Curia Global Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Emergent BioSolutions Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Jubilant HollisterStier LLC.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 PCI Pharma Services
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 SYNERLAB GROUP
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
13. Appendix
13.1 About Business Market Insights